STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere

New cancer drug trial offers hope for patients with rare aggressive tumour

CRISPR’s next act: the companies editing the epigenome to treat disease

Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing

How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies

The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as

Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity

Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra

Dad with Rare Cancer Says New Therapy Changed His Prognosis (Exclusive)